Aurora Mobile Partners with Moonshot AI to Provide Messaging Services and Verification Services for Kimi App
SHENZHEN, China, May 21, 2024 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading […]
JD.com Publishes Its Unaudited Interim Condensed Consolidated Financial Statements
BEIJING, May 21, 2024 (GLOBE NEWSWIRE) — JD.com, Inc. (“JD” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) […]
JD.com Announces Proposed Offering of US$1.5 Billion Convertible Senior Notes
BEIJING, May 21, 2024 (GLOBE NEWSWIRE) — JD.com, Inc. (“JD” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) […]
UP Fintech Holding Limited to Report First Quarter 2024 Financial Results on June 5, 2024
SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (“UP Fintech” or the “Company”) (NASDAQ: TIGR), a leading […]
Presto Automation Announces Fiscal Third Quarter 2024 Financial Results
Successful Pilots of Presto Voice™ with Pure AI and Spanish Language Capabilities Focuses on Voice AI Solution for Drive-Thrus By […]
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira® REYKJAVIK, Iceland and PARSIPPANY, N.J., May 21, 2024 (GLOBE NEWSWIRE) […]
CDT Environmental Technology Investment Holdings Limited Files Annual Report on Form 20-F
SHENZHEN, China, May 20, 2024 (GLOBE NEWSWIRE) — CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) (“CDT”), a leading provider […]
S&P reviews Banco Inter’s outlook to Stable and reaffirms its “brAA+” rating
BELO HORIZONTE, Brazil, May 20, 2024 (GLOBE NEWSWIRE) — Inter&Co (NASDAQ: INTR), the financial super app serving over 32 million […]
Workhorse Group Reports First Quarter 2024 Results
CINCINNATI, May 20, 2024 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company […]
SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
MIAMI, May 20, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with […]
